Wedbush Reiterates Outperform on Staar Surgical, Maintains $40 Price Target

Benzinga Newsdesk www.benzinga.com Negative 84.3%

Neg 84.3% Neu 0% Pos 0%

Wedbush analyst Michael Piccolo reiterates Staar Surgical (NASDAQ:STAA) with a Outperform and maintains $40 price target.